Europe’s equity investors finally have some IPOs to consider again, after the volatility caused by the spread of Covid-19 scuttled most deals in the first half of the year. But they remain selective: only companies in sectors that are either immune to the pandemic or have benefited from it will get a hearing. Aidan Gregory reports.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.